Cost burden and net monetary benefit loss of neonatal hypoglycaemia
نویسندگان
چکیده
منابع مشابه
Incremental cost-effectiveness ratio and net monetary benefit: Current use in pharmacoeconomics and future perspectives.
In evaluating the cost/effectiveness of therapeutic interventions (e.g. those based on innovative drugs or on Class-III medical devices), two main pharmacoeconomic parameters have been used over the past decades: the incremental cost-effectiveness ratio (ICER [1–3]) and the net monetary benefit (NMB [4–6]). The ICER and the NMB share some common features because they both require a pre-defined ...
متن کاملCost-Optimal and Net-Benefit Planning - A Parameterised Complexity View
Cost-optimal planning (COP) uses action costs and asks for a minimum-cost plan. It is sometimes assumed that there is no harm in using actions with zero cost or rational cost. Classical complexity analysis does not contradict this assumption; planning is PSPACE-complete regardless of whether action costs are positive or non-negative, integer or rational. We thus apply parameterised complexity a...
متن کاملHypoglycaemia and neonatal brain injury
The transition from fetal to neonatal life requires metabolic adaptation to ensure energy supply to vital organs and systems after separation from the placental circulation. Under normal conditions this is achieved through the mobilisation and use of alternative cerebral fuels (fatty acids, ketone bodies and lactate) when blood glucose concentration falls. The level of blood glucose (BG) concen...
متن کاملRapid detection of neonatal hypoglycaemia
The use of Dextrostix Reflectance Meter (DRM)* to measure blood glucose has been reported recently. The method has proved to be simnple, rapid, and accurate, and to correlate well with various reference methods (Mazzaferri et al., 1970; Jarret, Keen, and Hardwick, 1970; Schersten, 1971; Deckert and Futtrup, 1971). The handiness of the DRM seemed to make it an excellent tool in the diagnosis of ...
متن کاملRapid detection of neonatal hypoglycaemia
The use of Dextrostix Reflectance Meter (DRM)* to measure blood glucose has been reported recently. The method has proved to be simnple, rapid, and accurate, and to correlate well with various reference methods (Mazzaferri et al., 1970; Jarret, Keen, and Hardwick, 1970; Schersten, 1971; Deckert and Futtrup, 1971). The handiness of the DRM seemed to make it an excellent tool in the diagnosis of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Health Services Research
سال: 2021
ISSN: 1472-6963
DOI: 10.1186/s12913-021-06098-9